Načítá se...
Targeting B cells for inflammatory bowel disease treatment: back to the future
B cells are critical to immune homeostasis at mucosal surfaces including those of the gastrointestinal tract. B cell-related abnormalities, comprising of a lympho-plasmacytic infiltrate, as well as anti-microbial antibodies, are well reported in patients with inflammatory bowel disease (IBD). Howeve...
Uloženo v:
| Vydáno v: | Curr Opin Pharmacol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7894973/ https://ncbi.nlm.nih.gov/pubmed/33166872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coph.2020.10.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|